selinexor,Ruxolitinib
karyopharm therapeutics,novartis,incyte
['selinexor', '$kpti']
$kpti karyopharm announces presentation of updated phase 1 selinexor data in patients with treatment-na ve myelofibrosis at aacr 2023 #stocks #investing #stockmarket
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i